Murashko spoke about the influence of genetics on antithrombotic therapy

Brief retelling from RIA II

The patient’s genetic characteristics influence the individual response to drugs during antithrombotic therapy by 50%, said Russian Health Minister Mikhail Murashko.

Personalization of antithrombotic therapy is impossible without taking into account pharmacogenetics, the minister emphasized.

MOSCOW, October 10 - RIA Novosti. The patient’s genetic characteristics influence the patient’s individual response to medications during antithrombotic therapy by 50%, said Russian Health Minister Mikhail Murashko.

On Saturday, the minister spoke at the IV All-Russian Congress with international participation “Day of Combating Thrombosis in Russia.”

“An individual response to antithrombotic therapy consists of many factors: age, severity of the underlying disease, liver and kidney function, appropriate medications, nutrition, bad habits. All this forms 50% of the variability of the response. But the second 50% is, of course, the genetic characteristics of the patient,” the minister said.